Table 2.
Clinical Outcome in Hospital and During 30‐Day Follow‐up
| Number of patients, n=100 | |
|---|---|
| In hospital | |
| Mortality, n (%) | 0 (0.0) |
| MI, n (%) | 0 (0.0) |
| Stroke, n (%) | 1 (1.0) |
| Pacemaker implantation, n (%) | 10 (10.0) |
| Next‐day discharge, n (%) | 56 (56.0) |
| Early‐day discharge (≤3 d), n (%) | 82 (82.0) |
| Echocardiography | |
| AVA, cm2 | 1.71±0.48 |
| Mean gradient, mm Hg | 12.4±5.4 |
| Maximum velocity, m/s | 2.41±0.51 |
| LVEF, % | 60.2±9.1 |
| Moderate or severe paravalvular leakage, n (%) | 5 (5.0) |
| 30‐d follow‐up | |
| Mortality, n (%) | 0 (0.0) |
| MI, n (%) | 0 (0.0) |
| Stroke, n (%) | 1 (1.0) |
| New pacemaker implantation, n (%) | 4 (4.0) |
| Rehospitalization, n (%) | 11 (11.0) |
| Cardiac rehospitalization, n (%) | 8 (8.0) |
| Cardiac rehospitalization by watch, n (%) | 6 (6.0) |
| Echocardiography | |
| AVA, cm2 | 1.63±0.37 |
| Mean gradient, mm Hg | 11.7±5.3 |
| Maximum velocity, m/s | 2.32±0.56 |
| LVEF, % | 59.9±9.5 |
| Moderate or severe paravalvular leakage, n (%) | 5 (5.0) |
Data are presented as mean±SD or no. (%). AVA indicates aortic valve area; LVEF, left ventricular ejection fraction; and MI, myocardial infarction.